跳至主要内容
临床试验/NL-OMON56245
NL-OMON56245招募中不适用

Elucidating the high cardiovascular disease risk in South Asians: focus on monocyte phenotype and incretin hormones - CAMI study

Interne Geneeskunde0 个研究点目标入组 48 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Males and females of South Asian or Dutch European ethnicity
  • - Age from 18 to 30 years old
  • - BMI 18 - 25 kg/m2
  • - Capable of giving informed consent

排除标准

  • - (auto-) immune disease(s) including type 1 or 2 diabetes mellitus, chronic
  • kidney disease, hepatic disease, inflammatory bowel disease, thyroid disease
  • and rheumatoid arthritis. - Genetic lipid-associated disorders such as familial
  • hypercholesterolemia - Any chronic renal or hepatic disease - Use of medication
  • known to influence glucose and/or lipid metabolism (e.g. beta-blockers,
  • antidepressants, corticosteroids) - Abuse of alcohol or other substances -
  • Smoking - Vigorous exercise (>3 times/week) - Milk or soy allergy -
  • Contrainindications for the InBody720 scan, such as a pacemaker - Participation
  • in an intensive weight loss program or vigorous exercise program during the
  • last year before the start of the study - laboratory abnormalities that could
  • point towards an underlying disease

研究者

发起方
Interne Geneeskunde

相似试验